Cargando…

Conservation of immune gene signatures in solid tumors and prognostic implications

BACKGROUND: Tumor-infiltrating leukocytes can either limit cancer growth or facilitate its spread. Diagnostic strategies that comprehensively assess the functional complexity of tumor immune infiltrates could have wide-reaching clinical value. In previous work we identified distinct immune gene sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chifman, Julia, Pullikuth, Ashok, Chou, Jeff W., Bedognetti, Davide, Miller, Lance D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118876/ https://www.ncbi.nlm.nih.gov/pubmed/27871313 http://dx.doi.org/10.1186/s12885-016-2948-z

Ejemplares similares

Immune gene signatures and tumor intrinsic markers delineate novel immunogenic subtypes of breast cancer
por: Miller, Lance D, et al.
Publicado: (2014)

Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types
por: Routh, Eric D., et al.
Publicado: (2020)

Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes
por: Pullikuth, Ashok K., et al.
Publicado: (2021)

Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden
por: Raj, Shailaja K. S., et al.
Publicado: (2022)

Tumor mutational burden is a determinant of immune-mediated survival in breast cancer
por: Thomas, Alexandra, et al.
Publicado: (2018)

Systems biology approach to studying proliferation-dependent prognostic subnetworks in breast cancer
por: Song, Qianqian, et al.
Publicado: (2015)

Prognostic implications of immune-related eight-gene signature in pediatric brain tumors
por: Wang, Yi, et al.
Publicado: (2021)

Cancer-Specific Immune Prognostic Signature in Solid Tumors and Its Relation to Immune Checkpoint Therapies
por: Das, Shaoli, et al.
Publicado: (2020)

The immune landscape of solid pediatric tumors
por: Sherif, Shimaa, et al.
Publicado: (2022)

A phylogenetic approach to inferring the order in which mutations arise during cancer progression
por: Gao, Yuan, et al.
Publicado: (2022)

Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer
por: Xiong, Hui, et al.
Publicado: (2021)

Immune implication of an autophagy-related prognostic signature in uveal melanoma
por: Chuah, Samuel, et al.
Publicado: (2021)

An invariants-based method for efficient identification of hybrid species from large-scale genomic data
por: Kubatko, Laura S., et al.
Publicado: (2019)

Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature
por: Meng, Xianhong, et al.
Publicado: (2023)

Immune landscape and prognostic gene signatures in gastric cancer: implications for cachexia and clinical outcomes
por: Sui, Xiangyu, et al.
Publicado: (2023)

Clonal Hematopoiesis: Updates and Implications at the Solid Tumor-Immune Interface
por: Buttigieg, Marco M., et al.
Publicado: (2023)

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting
por: Sherif, Shimaa, et al.
Publicado: (2022)

Prognostic Implications of Immune-Related Genes’ (IRGs) Signature Models in Cervical Cancer and Endometrial Cancer
por: Ding, Hao, et al.
Publicado: (2020)

Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2021)

Prognostic and Immune Implications of a Novel Pyroptosis-Related Five-Gene Signature in Breast Cancer
por: Zheng, Yuanyuan, et al.
Publicado: (2022)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

Immune cell infiltration-associated signature in colon cancer and its prognostic implications
por: Deng, Dan, et al.
Publicado: (2021)

Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
por: Bertucci, Francois, et al.
Publicado: (2022)

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
por: Bertucci, François, et al.
Publicado: (2018)

Toward the identification of genetic determinants of breast cancer immune responsiveness
por: Simeone, Ines, et al.
Publicado: (2015)

Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance
por: Zadka, Łukasz, et al.
Publicado: (2020)

MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
por: Guo, Qinglong, et al.
Publicado: (2021)

Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer
por: Wang, Yuanyuan, et al.
Publicado: (2021)

Identification of Prognostic Genes and Immune Landscape Signatures Based on Tumor Microenvironment in Lung Adenocarcinoma
por: Han, Pengkai, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC
por: Qin, Haotian, et al.
Publicado: (2023)

Exploring Immune-Related Prognostic Signatures in the Tumor Microenvironment of Colon Cancer
por: Cao, Lichao, et al.
Publicado: (2022)

Prognostic value and their clinical implication of 89-gene signature in glioma
por: Shahid, Muhammad, et al.
Publicado: (2016)

Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment
por: Sun, Mengyu, et al.
Publicado: (2020)

Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020)

Prognostic implications of metabolism-associated gene signatures in colorectal cancer
por: Miao, Yandong, et al.
Publicado: (2020)

Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
por: Luo, Huan, et al.
Publicado: (2020)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

Meta-analysis and metagenes: CXCL-13-driven signature as a robust marker of intratumoral immune response and predictor of breast cancer chemotherapeutic outcome
por: Bedognetti, Davide, et al.
Publicado: (2014)

COVID-19 and flu: conserved or specific immune signature?
por: Paget, Christophe, et al.
Publicado: (2021)

Immune gene signatures as prognostic criteria for cancer patients
por: Larionova, Irina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vfhmfe9l6bbqepaorji61jjju1